Dr. Adeniyi Ashimi is a pharmacist who is specialized in Pharmacotherapy in Hampton, Virginia. Patients can reach him at 100 Emancipation Dr, Hampton or contact him on 757-722-9961. Active license number of Dr. Adeniyi Ashimi is 0202204928 for Pharmacotherapy in Virginia. Dr. Adeniyi Ashimi is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Adeniyi Ashimi speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Adeniyi Ashimi are as mentioned below.
NPI Number:
1588627616
NPI Enumeration Date:
10 Apr, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Adeniyi Ashimi are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
0202204928
Virginia
Primary
Pharmacist
0202204928
Virginia
Secondary
Pharmacotherapy
0202204928
Virginia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
100 Emancipation Dr, Hampton, Virginia
Zip:
23667-0001
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Adeniyi Ashimi at 100 Emancipation Dr, Hampton, Virginia or can call on phone at 757-722-9961.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.